Acetylcholinesterase inhibitors (AChEIs) are a class of compounds that inhibit the enzyme acetylcholinesterase, which is responsible for breaking down the neurotransmitter acetylcholine in the synaptic cleft. These inhibitors are primarily used to treat conditions like Alzheimer's disease, but recent research has been exploring their potential in the context of cancer treatment.
